Main > A2. TRADEMARK. INDEX. V-Vm > Viagra

Product USA. P

GENERIC NAME This data is not available for free
STRUCTURE 5-[2-ethoxy-5-(4-methyl piperazin-1-yl-sulphonyl)-phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyraz olo[4,3-d]pyrimidin-7-one
INDICATION'S Erectile Dysfunction Treat
LEGAL DISPUTES Co is sueing
- Bayer AG
- GlaxoSmithKline &
- Lilly Icos
for infringing Co.'s patents
MECHANISM OF ACTION This data is not available for free
SALES VALUE in 2002: $1.74 Billion
SIDE EFFECT'S News late last month that federal authorities are investigating the use of drug for possible link to a handful of cases of BLINDNESS in men only adds woes to a market that may be stagnating. FDA is acting on 43 reports of blindness caused by NAION among patients taking ED drugs. Of these, 38 had taken Viagra. The number of men taking ED drugs is estimated at > 25 million, with about 23 million taking Viagra. The potential world market is estimated at 189 million. Co. issued a statement last week claiming there is no evidence showing that NAION occurred more frequently in men taking Viagra than in men of similar age & health who did not take the drug. Co. cited 103 clinical trials with 13,000 patients in which no case of NAION was reported
UPDATE 06.05
COMPANY This data is not available for free
LITERATURE REF. This data is not available for free
PATENT NUMBER This data is not available for free

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back